Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Laboratorios Farmaceuticos ROVI SA    41L   ES0157261019

End-of-day quote. End-of-day quote Deutsche Boerse AG - 05/20
6.628 EUR   -0.73%
2012 LABORATORIOS FARMACEUTICOS ROVI SA: ex-dividend day for annual dividend
2011 LABORATORIOS: Alentia Biotech, a joint venture of Ferrer and ROVI, plans t..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Upcoming events on LABORATORIOS FARMACEUTICOS
06/12/13 | 05:00am Annual General Meeting - 1st Session
06/13/13 | 05:00am Annual General Meeting - 2nd Session (if required)
07/03/13 ex-dividend day for annual dividend
08/01/13 Q2 2013 Earnings Release (Projected)

Past events on LABORATORIOS FARMACEUTICOS
02/21/13 | 09:00am Q4 2012 Earnings Call
02/21/13 Q4 2012 Earnings Release
11/14/12 | 11:20am Jefferies Global Healthcare Conference
11/08/12 Q3 2012 Earnings Release
Annual publications
Previous yearNext Year
Annual results2010201120122013 (e)2014 (e)
Sales
Million €
Released
Forecast
Spread
159
158
0,37%
185
182
1,7%
202
202
-0,11%

218

237
Operating income (EBITDA)
Million €
Released
Forecast
Spread
29,6
29,8
-0,77%
23,7
22,7
4,5%
26,4
25,8
2,3%

32,1

39,8
Operating profit (EBIT)
Million €
Released
Forecast
Spread
26,0
26,7
-2,7%
19,0
18,7
1,7%
21,7
20,7
4,7%

26,1

33,7
Pre-Tax Profit (EBT)
Million €
Released
Forecast
Spread
25,9
29,3
-11%
18,9
18,9
0,06%
20,8
20,6
1,4%

27,0

34,8
Net income
Million €
Released
Forecast
Spread
24,6
25,6
-4,0%
18,1
17,0
6,9%
19,5
19,3
1,0%

24,5

32,3
EPS
 €
Released
Forecast
Spread
0,49
0,49
0,18%
0,36
0,32
12%
0,39
0,39
1,0%

0,48

0,63
Announcement Date02/24/201102/21/201202/21/2013

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ3
2012
Q4
2012
Q1
2013
Q2
2013 (e)
Q3
2013 (e)
Sales
Million €
Released
Forecast
Spread
48,7
49,1
-0,84%
47,3
48,6
-2,7%
54,1
54,8
-1,3%

58,2

54,3
Operating income (EBITDA)
Million €
Released
Forecast
Spread
5,40
6,19
-13%
4,99
5,08
-1,8%
7,60
8,05
-5,6%

11,0

7,59
Operating profit (EBIT)
Million €
Released
Forecast
Spread
4,00
5,03
-20%
4,08
4,18
-2,4%
5,99
6,32
-5,3%

9,44

5,97
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million €
Released
Forecast
Spread
3,60
3,90
-7,7%
2,88
3,00
-3,9%
5,34
5,50
-2,9%




EPS
 €
Released
Forecast
Spread
0,07
0,14
-49%
0,06
0,08
-25%

0,25

0,35

0,21
Announcement Date11/08/201202/21/201304/24/2013

© 2013 Thomson Reuters
© 2013 Factset
Advertisement
Net sales - Rate of surprise
Laboratorios Farmaceuticos : Net sales - Rate of surprise
Operating profit - Rate of surprise
Laboratorios Farmaceuticos : Operating profit - Rate of surprise
EPS - Rate of surprise
Laboratorios Farmaceuticos : EPS - Rate of surprise
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.